Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News TNF Pharmaceuticals Inc TNFA

TNF Pharmaceuticals, Inc., formerly MyMD Pharmaceuticals, Inc., is a clinical-stage biopharmaceutical company focused on developing novel therapies for age-related diseases and autoimmune and inflammatory conditions. It is focused on developing and commercializing two therapeutic platforms based on well-defined therapeutic targets: MYMD-1 and Supera-CBD. MYMD-1 is a drug platform based on a... see more

Recent & Breaking News (NDAQ:TNFA)

INVESTIGATION ALERT: Halper Sadeh LLP Continues to Investigate the Following Companies; Shareholders are Encouraged to Contact the Firm - IPHI, TNAV, NAV, AKER

GlobeNewswire December 12, 2020

SHAREHOLDER ALERT: WeissLaw LLP Reminds WDR, AKER, CBMG, and HLIX Shareholders About Its Ongoing Investigations

PR Newswire December 10, 2020

ALERT: Halper Sadeh LLP Encourages IPHI, EIGI, ARA, and AKER Shareholders to Contact the Firm

PR Newswire December 5, 2020

SHAREHOLDER ALERT: WeissLaw LLP Reminds AKER, CBMG, HLIX, and MCAC Shareholders About Its Ongoing Investigations

PR Newswire December 3, 2020

AKERS BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Akers Biosciences, Inc. - AKER

Business Wire December 3, 2020

Akers' Proposed Merger Partner MyMD Pharmaceuticals Announces Issuance of Key Patent

Business Wire December 2, 2020

Halper Sadeh LLP Reminds Shareholders About Its Ongoing Merger Investigations; Investors are Encouraged to Contact the Firm - NAV, UROV, HDS, AKER

GlobeNewswire December 1, 2020

SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of NAV, UROV, AKER, and EMIS Mergers

GlobeNewswire December 1, 2020

Halper Sadeh LLP Continues to Investigate the Following Mergers; Investors are Encouraged to Contact the Firm - UROV, HDS, AKER, GV

GlobeNewswire November 25, 2020

Lifshitz Law Firm, P.C. Announces Investigation of AKER, EMIS, HDS, IPHI, PNM, TGC, GV and UROV

PR Newswire November 25, 2020

ALERT: Halper Sadeh LLP Continues to Investigate the Following Mergers; Investors are Encouraged to Contact the Firm - HDS, AKER, UROV

ACCESSWIRE IA November 20, 2020

WeissLaw LLP Reminds ALSK, EIGI, AKER, and TNAV Shareholders About Its Ongoing Investigations

PR Newswire November 19, 2020

SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of HDS, UROV, AKER, and TGC Mergers

GlobeNewswire November 19, 2020

SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Akers Biosciences, Inc. - AKER

PR Newswire November 18, 2020

REMINDER: Akers Biosciences Schedules Conference Call to Discuss Merger with MyMD Pharmaceuticals

Business Wire November 18, 2020

Halper Sadeh LLP Investigates the Following Mergers; Shareholders are Encouraged to Contact the Firm - HDS, UROV, AKER, NAV

GlobeNewswire November 18, 2020

AKERS BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Akers Biosciences, Inc. - AKER

Business Wire November 17, 2020

RM LAW Announces Investigation of Akers Biosciences, Inc.

PR Newswire November 17, 2020

Moore Kuehn Encourages CGIX, AKER, TGC and DNKN Investors to Contact Law Firm

PR Newswire November 17, 2020

SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Akers Biosciences, Inc. Merger

GlobeNewswire November 13, 2020